arginine and acipimox

arginine has been researched along with acipimox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boffano, GM; Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Taliano, M1
Casanueva, FF; Cordido, F; de Vries, WR; Dieguez, C; Koppeschaar, HP; van Dam, PS; van Thiel, E; Veldhuyzen, BF1
Cattaneo, A; Cavagnini, F; Fatti, LM; Filippini, B; Grasso, A; Moro, M; Orsini, F; Pecori Giraldi, F; Scacchi, M1

Trials

1 trial(s) available for arginine and acipimox

ArticleYear
Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
    Clinical endocrinology, 2003, Volume: 58, Issue:2

    Topics: Adenoma; Adolescent; Adult; Aged; Area Under Curve; Arginine; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Male; Middle Aged; Pituitary Neoplasms; Predictive Value of Tests; Pyrazines; Stimulation, Chemical

2003

Other Studies

2 other study(ies) available for arginine and acipimox

ArticleYear
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:3

    Topics: Adult; Arginine; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypolipidemic Agents; Obesity; Pyrazines

1996
The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.
    European journal of endocrinology, 2010, Volume: 163, Issue:2

    Topics: Adult; Aged; Arginine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypolipidemic Agents; Hypopituitarism; Insulin; Insulin-Like Growth Factor I; Linear Models; Lipolysis; Male; Middle Aged; Obesity; Pyrazines

2010